CAS No 57852-57-0 IDARUBICIN HYDROCHLORIDE Pharmaceutical Intermediates

- High Purity: Our Idarubicin HCl is manufactured under strict quality standards to ensure high purity and potency.
- Multiple Applications: Mainly used to treat various cancers, including acute myeloid leukemia (AML) and breast cancer.
- Reliable Supplier: As a factory integrating production and trading, we ensure seamless supply chain and consistent product availability.
- Manufacturing Expertise: Our state-of-the-art facilities and experienced team ensure the highest quality in drug production.
- Regulatory Compliance: Our products comply with international pharmaceutical regulations to ensure safety and effectiveness.

product details

Product details

Product detail

Idarubicin hydrochloride is an anthracycline antibiotic that plays a vital role in the pharmaceutical industry, especially in the field of oncology. It is a potent chemotherapy drug that is primarily used to treat various hematological malignancies, including acute myeloid leukemia (AML) and certain types of breast cancer. Idarubicin hydrochloride has a unique chemical structure and mechanism of action, and has become an important component of cancer treatment regimens.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Advantages

The advantages of idarubicin hydrochloride are not limited to its chemical properties. Its clinical benefits and excellent manufacturing process make it the first choice of the pharmaceutical industry.

1. Cancer treatment efficacy: Idarubicin hydrochloride is known for its potent anti-tumor activity. It works by intercalating into DNA, thereby inhibiting DNA and RNA synthesis, which are essential for cancer cell proliferation. This mechanism makes it particularly effective against rapidly dividing cells, which are a hallmark of many cancers.

2. Reduced cardiotoxicity: Compared with other anthracyclines, idarubicin hydrochloride has a lower incidence of cardiotoxicity, making it a safer option for patients who may be at risk for heart-related side effects.

3. Flexible dosing regimen: The pharmacokinetics of idarubicin hydrochloride allow for a flexible dosing regimen that can be customized to the needs of individual patients, thereby enhancing the therapeutic effect.

4. Full Quality Control: As a factory integrating production and trading, we implement strict quality control measures throughout the manufacturing process. This ensures that every batch of Idarubicin Hydrochloride meets the highest quality and safety standards.

5. Committed to Innovation: Our factory is committed to continuous research and development, striving to improve our products and explore new applications of Idarubicin Hydrochloride in the pharmaceutical field.

Physical and Chemical Properties

Idarubicin hydrochloride possesses unique physical and chemical properties that contribute to its effectiveness as a therapeutic agent.

- Molecular formula: C26H28ClNO9

- Molecular weight: 533.95 g/mol

- Appearance: Orange to red solid.

- Stability: Idarubicin hydrochloride exhibits good stability under proper storage conditions, ensuring a longer shelf life and maintaining its potency.

These properties not only enhance its therapeutic efficacy but also facilitate its incorporation into various dosage forms, including injections and lyophilized powders.

In summary

In conclusion, Idarubicin HCl is an important pharmaceutical product with significant advantages in cancer treatment. Its high purity, efficacy and low side effects make it the first choice of healthcare professionals. As an integrated production and trading plant, we are committed to providing high-quality Idarubicin HCl that meets the needs of the pharmaceutical industry. Our expertise, regulatory compliance and dedication to innovation ensure that we remain a reliable partner in the fight against cancer. Choose Idarubicin HCl as a reliable solution in the field of oncology and experience the difference in patient care.